Literature DB >> 17158101

Notch signaling suppresses p38 MAPK activity via induction of MKP-1 in myogenesis.

Kunio Kondoh1, Kazunori Sunadome, Eisuke Nishida.   

Abstract

Cross-talks among intracellular signaling pathways are important for the regulation of cell fate decisions and cellular responses to extracellular signals. Both the Notch pathway and the MAPK pathways play important roles in many biological processes, and the Notch pathway has been shown to interact with the ERK-type MAPK pathway. However, its interaction with the other MAPK pathways is unknown. Here we show that Notch signaling activation in C2C12 cells suppresses the activity of p38 MAPK to inhibit myogenesis. Our results show that Notch specifically induces expression of MKP-1, a member of the dual-specificity MAPK phosphatase, which directly inactivates p38 to negatively regulate C2C12 myogenesis. The Notch-induced expression of MKP-1 is shown to depend on RBP-J. Moreover, inhibition of MKP-1 expression by short interfering RNA suppresses p38 inactivation and partially rescues the negative regulation of myogenesis. These results reveal a novel cross-talk between the Notch pathway and the p38 MAPK pathway that is mediated by Notch induction of MKP-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158101     DOI: 10.1074/jbc.M607630200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  Regulation of skeletal myogenesis by Notch.

Authors:  Matthew F Buas; Tom Kadesch
Journal:  Exp Cell Res       Date:  2010-05-07       Impact factor: 3.905

2.  Notch signaling is necessary to maintain quiescence in adult muscle stem cells.

Authors:  Christopher R R Bjornson; Tom H Cheung; Ling Liu; Pinky V Tripathi; Katherine M Steeper; Thomas A Rando
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

Review 3.  Notch signaling in CD4 and CD8 T cell development.

Authors:  Karen Laky; B J Fowlkes
Journal:  Curr Opin Immunol       Date:  2008-04-21       Impact factor: 7.486

4.  Notch3 and Mef2c proteins are mutually antagonistic via Mkp1 protein and miR-1/206 microRNAs in differentiating myoblasts.

Authors:  Jeffrey Gagan; Bijan K Dey; Ryan Layer; Zhen Yan; Anindya Dutta
Journal:  J Biol Chem       Date:  2012-10-10       Impact factor: 5.157

5.  Estrogen-related receptor α regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway.

Authors:  Jennifer Murray; Janice M Huss
Journal:  Am J Physiol Cell Physiol       Date:  2011-05-11       Impact factor: 4.249

6.  BMP signaling balances murine myeloid potential through SMAD-independent p38MAPK and NOTCH pathways.

Authors:  Brandoch D Cook; Todd Evans
Journal:  Blood       Date:  2014-06-03       Impact factor: 22.113

7.  Combined Tbet and IL12 gene therapy elicits and recruits superior antitumor immunity in vivo.

Authors:  Yanyan Qu; Lu Chen; Devin B Lowe; Walter J Storkus; Jennifer L Taylor
Journal:  Mol Ther       Date:  2012-01-03       Impact factor: 11.454

8.  Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype.

Authors:  Heather R Tiffin; Zandra A Jenkins; Mary J Gray; Sophia R Cameron-Christie; Jennifer Eaton; Salim Aftimos; David Markie; Stephen P Robertson
Journal:  Neurogenetics       Date:  2013-03-02       Impact factor: 2.660

9.  Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis.

Authors:  Srinivas Koduru; Raj Kumar; Sowmyalakshmi Srinivasan; Mark B Evers; Chendil Damodaran
Journal:  Mol Cancer Ther       Date:  2010-01-06       Impact factor: 6.261

10.  Novel cross-talk between three cardiovascular regulators: thrombin cleavage fragment of Jagged1 induces fibroblast growth factor 1 expression and release.

Authors:  Maria Duarte; Vihren Kolev; Doreen Kacer; Carla Mouta-Bellum; Raffaella Soldi; Irene Graziani; Aleksandr Kirov; Robert Friesel; Lucy Liaw; Deena Small; Joseph Verdi; Thomas Maciag; Igor Prudovsky
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.